Step up: It’s the call for Fierce 15 nominations

Send us your nominations for the Fierce 15 2017 awards

It’s summer: It's hot, the news flow starts to slow, and attentions turn to the beach, easy reads and suntans. But at FierceBiotech, we know innovation doesn’t slow down, and it’s time again to call on you to nominate your Fierce 15 for 2017.

The Fierce 15 celebrates the best of pre-IPO biotechs working on the best biomedical science in the world—we want to see truly cutting-edge biotechnology, executive teams and your reasons why they should join the elite of former Fierce 15 winners.

Want to know what it takes? Take a look at last year’s winners and what their executives had to say.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

So, have you got a biotech in mind? Then fill in the form below and let us know before mid-August:

Suggested Articles

The response rate was lower in the ONCOS-102 arm than the control cohort, but Targovax saw positives elsewhere.

The €13.9 million series B round will fund a phase 1/2 trial of a therapeutic vaccine in patients with non-small cell lung cancer.

Precision oncology firm Notable Labs is launching its first self-sponsored clinical trial, designed from the ground up to help validate its platform.